MifaMurtide 5mg 5mg | Purity Not Available
Adooq Bioscience
Mifamurtide is a liposomal formulation containing a muramyl dipeptide (MDP) analogue with potential immunomodulatory and antineoplastic activities
More Information Supplier PageMifamurtide is a liposomal formulation containing a muramyl dipeptide (MDP) analogue with potential immunomodulatory and antineoplastic activities
More Information Supplier PageMifamurtide is a liposomal formulation containing a muramyl dipeptide (MDP) analogue with potential immunomodulatory and antineoplastic activities
More Information Supplier PageApaziquone is an indolequinone bioreductive prodrug and analog of mitomycin C with potential antineoplastic and radiosensitization activities.
More Information Supplier PageML-3043 is a p38 MAPK inhibitor (IC50 = 0.38 ??M). Inhibits the release of IL-1?? and TNF-?? in a peripheral blood mononuclear cell (PBMC) assay (IC50 values are 0.039 and 0.16 ??M respectively).
More Information Supplier PageTMPA is a novel small molecule that binds to orphan Nuclear Receptor Nur77 with high affinity (Kd = 1.45 ?? 0.35 ??M), and interferes with the Nur77-LKB1 interaction.
More Information Supplier PageTMPA is a novel small molecule that binds to orphan Nuclear Receptor Nur77 with high affinity (Kd = 1.45 ?? 0.35 ??M), and interferes with the Nur77-LKB1 interaction.
More Information Supplier PageTMPA is a novel small molecule that binds to orphan Nuclear Receptor Nur77 with high affinity (Kd = 1.45 ?? 0.35 ??M), and interferes with the Nur77-LKB1 interaction.
More Information Supplier PageTMPA is a novel small molecule that binds to orphan Nuclear Receptor Nur77 with high affinity (Kd = 1.45 ?? 0.35 ??M), and interferes with the Nur77-LKB1 interaction.
More Information Supplier Page